Burkholderia species infections in patients with cystic fibrosis in British Columbia, Canada: 30 years' experience

Annals of the American Thoracic Society

Volumn 12, Issue 1, 2015, Pages 70-78

  Zlosnik, James E A ^a   Zhou, Guohai ^a   Brant, Rollin ^a   Henry, Deborah A ^a   Hird, Trevor J ^a   Mahenthiralingam, Eshwar ^b   Chilvers, Mark A ^c   Wilcox, Pearce ^d   Speert, David P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c BC CHILDREN S HOSPITAL   (Canada)

^d ST PAUL S HOSPITAL   (Canada)

Author keywords

Burkholderia cepacia complex; Burkholderia gladioli; Cystic fibrosis; Sex; Survival

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACTERIAL STRAIN; BURKHOLDERIA; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA GLADIOLI; BURKHOLDERIA INFECTION; BURKHOLDERIA MULTIVORANS; CANADA; CHILD; CLINICAL EVALUATION; CLINICAL STUDY; CYSTIC FIBROSIS; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROBIOLOGY; PRESCHOOL CHILD; PREVALENCE; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; SEX; STATISTICAL ANALYSIS; SURVIVAL; YOUNG ADULT; BURKHOLDERIA INFECTIONS; CLINICAL TRIAL; COMPLICATION; FOLLOW UP; FORECASTING; GENETICS; INCIDENCE; INFANT; ISOLATION AND PURIFICATION; MULTICENTER STUDY; RETROSPECTIVE STUDY;

BACTERIAL DNA;

ADOLESCENT; ADULT; BRITISH COLUMBIA; BURKHOLDERIA; BURKHOLDERIA INFECTIONS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DNA, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; INCIDENCE; INFANT; MALE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 84922431596     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201408-395OC     Document Type: Article

References (51)

1. Vandamme P, Dawyndt P. Classification and identification of the Burkholderia cepacia complex: past, present and future. Syst Appl Microbiol 2011;34:87-95.
2. Peeters C, Zlosnik JEA, Spilker T, Hird TJ, Lipuma JJ, Vandamme P. Burkholderia pseudomultivorans sp. nov., a novel Burkholderia cepacia complex species from human respiratory samples and the rhizosphere. Syst Appl Microbiol 2013;36:483-489.
3. Hauser AR, Jain M, Bar-Meir M, McColley SA. Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev 2011;24:29-70.
4. Jassem AN, Zlosnik JEA, Henry DA, Hancock REW, Ernst RK, Speert DP. In vitro susceptibility of Burkholderia vietnamiensis to aminoglycosides. Antimicrob Agents Chemother 2011;55: 2256-2264.
5. Nzula S, Vandamme P, Govan JR. Influence of taxonomic status on the in vitro antimicrobial susceptibility of the Burkholderia cepacia complex. J Antimicrob Chemother 2002;50:265-269.
6. Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996;143:1007-1017.
7. LiPuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990;336:1094-1096.
8. Mahenthiralingam E, Vandamme P, Campbell ME, Henry DA, Gravelle AM, Wong LT, Davidson AG, Wilcox PG, Nakielna B, Speert DP. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans . Clin Infect Dis 2001;33:1469-1475.
9. De Soyza A, Meachery G, Hester KLM, Nicholson A, Parry G, Tocewicz K, Pillay T, Clark S, Lordan JL, Schueler S, et al. Lung transplantation for patients with cystic fibrosis and Burkholderia cepacia complex infection: a single-center experience. J Heart Lung Transplant 2010; 29:1395-1404.
10. Hopkins PM, Kidd TJ, Coulter C, Feather IH, Derrington P, Bell SC. Death after lung transplantation in cystic fibrosis patients infected with Burkholderia cepacia . Am J Respir Crit Care Med 2009; 179:257-258.
11. Murray S, Charbeneau J, Marshall BC, LiPuma JJ. Impact of Burkholderia infection on lung transplantation in cystic fibrosis. Am J Respir Crit Care Med 2008;178:363-371.
12. LiPuma JJ. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis? Transpl Infect Dis 2001;3:149-160.
13. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984;104:206-210.
14. Whiteford ML, Wilkinson JD, McColl JH, Conlon FM, Michie JR, Evans TJ, Paton JY. Outcome of Burkholderia (Pseudomonas) cepacia colonisation in children with cystic fibrosis following a hospital outbreak. Thorax 1995;50:1194-1198.
15. Govan JR, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, Greening AP, Webb AK. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993;342:15-19.
16. Drevinek P, Vosahlikova S, Cinek O, Vavrova V, Bartosova J, Pohunek P, Mahenthiralingam E. Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic. J Med Microbiol 2005;54:655-659.
17. Govan JR, Brown AR, Jones AM. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol 2007;2:153-164.
18. Johnson WM, Tyler SD, Rozee KR. Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol 1994;32: 924-930.
19. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002;8:181-187.
20. Drevinek P, Mahenthiralingam E. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin Microbiol Infect 2010;16:821-830.
21. Baldwin A, Mahenthiralingam E, Kathleen M, Honeybourne D, Maiden MCJ, John R, Speert DP, LiPuma JJ, Vandamme P, Dowson CG, et al. Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex. J Clin Microbiol 2005;43:4665-4673.
22. Kalish LA, Waltz DA, Dovey M, Potter-Bynoe G, McAdam AJ, LiPuma JJ, Gerard C, Goldmann D. Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med 2006;173:421-425.
23. Dedeckova K, Fila L, Skalicka V, Bartosova J, Kucerova T, Vavrova V, Zemkova D, Kalferstova L, Melter O, Cinek O, et al. PCR detection of Burkholderia cepacia complex as one of key factors to handle a longterm outbreak. J Cyst Fibros 2012;11:440-445.
24. Martina P, Bettiol M, Vescina C, Montanaro P, Mannino MC, Prieto CI, Vay C, Naumann D, Schmitt J, Yantorno O, et al. Genetic diversity of Burkholderia contaminans isolates from cystic fibrosis patients in Argentina. J Clin Microbiol 2013;51:339-344.
25. Campana S, Taccetti G, Ravenni N, Favari F, Cariani L, Sciacca A, Savoia D, Collura A, Fiscarelli E, De Intinis G, et al. Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy. J Clin Microbiol 2005;43: 5136-5142.
26. Smith DL, Gumery LB, Smith EG, Stableforth DE, Kaufmann ME, Pitt TL. Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission. J Clin Microbiol 1993; 31:3017-3022.
27. Zahariadis G, Levy MH, Burns JL. Cepacia-like syndrome caused by Burkholderia multivorans . Can J Infect Dis Med Microbiol 2003;14: 123-125.
28. Shafiq I, Carroll MP, Nightingale JA, Daniels TVW. Cepacia syndrome in a cystic fibrosis patient colonised with Burkholderia multivorans. BMJ Case Rep 2011;2011: pii: bcr0820103296.
29. Blackburn L, Brownlee K, Conway S, Denton M. "Cepacia syndrome" with Burkholderia multivorans, 9 years after initial colonization. J Cyst Fibros 2004;3:133-134.
30. Zlosnik JEA, Henry DA, Mahenthiralingam E, Hird TJ, Davidson AGF, Wilcox PG, Chilvers M, Speert DP. 30 Years of Burkholderia cepacia complex infection in Vancouver and British Columbia, from 1981-2011 [abstract]. Pediatr Pulmonol 2012;47:343-344.
31. Stern RC. The diagnosis of cystic fibrosis. N Engl J Med 1997;336: 487-491.
32. Henry DA, Mahenthiralingam E, Vandamme P, Coenye T, Speert DP. Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J Clin Microbiol 2001;39:1073-1078.
33. Mahenthiralingam E, Bischof J, Byrne SK, Radomski C, Davies JE, Av-Gay Y, Vandamme P. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III. J Clin Microbiol 2000;38: 3165-3173.
34. Mahenthiralingam E, Campbell ME, Henry DA, Speert DP. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting. J Clin Microbiol 1996;34:2914-2920.
35. Lipuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev 2010;23:299-323.
36. Whitby PW, Pope LC, Carter KB, John J, Stull TL, LiPuma JJ. Species-specific PCR as a tool for the identification of Burkholderia gladioli species-specific PCR as a tool for the identification of Burkholderia gladioli. J Clin Microbiol 2000;38:282-285.
37. Zlosnik JEA, Costa PS, Brant R, Mori PYB, Hird TJ, Fraenkel MC, Wilcox PG, Davidson AGF, Speert DP. Mucoid and nonmucoid Burkholderia cepacia complex bacteria in cystic fibrosis infections. Am J Respir Crit Care Med 2011;183:67-72.
38. Therneau TM, Grambsch PM. Modeling survival data: extending the Cox model. New York: Springer; 2000.
39. Little RJA, Rubin DB. Statistical analysis with missing data. New York: Wiley & Sons; 1987.
40. Sweezey NB, Ratjen F. The cystic fibrosis gender gap: potential roles of estrogen. Pediatr Pulmonol 2013;49:309-317.
41. Jones AM, Dodd ME, Govan JRW, Barcus V, Doherty CJ, Morris J, Webb AK. Burkholderia cenocepacia and Burkholderia multivorans: influence on survival in cystic fibrosis. Thorax 2004;59:948-951.
42. Courtney JM, Dunbar KEA, McDowell A, Moore JE, Warke TJ, Stevenson M, Elborn JS. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. J Cyst Fibros 2004;3: 93-98.
43. McIntyre K. Gender and survival in cystic fibrosis. Curr Opin Pulm Med 2013;19:692-697.
44. Pope CE, Short P, Carter PE. Species distribution of Burkholderia cepacia complex isolates in cystic fibrosis and non-cystic fibrosis patients in New Zealand. J Cyst Fibros 2010;9:442-446.
45. Reik R, Spilker T, LiPuma JJ. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol 2005;43:2926-2928.
46. Drevinek P, Cinek O, Melter J, Langsadl L, Navesnakova Y, Vavrova V. Genomovar distribution of the Burkholderia cepacia complex differs significantly between Czech and Slovak patients with cystic fibrosis. J Med Microbiol 2003;52:603-604.
47. Brisse S, Cordevant C, Vandamme P, Bidet P, Loukil C, Chabanon G, Bingen E. Species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis species distribution and ribotype diversity of Burkholderia cepacia complex isolates from French patients with cystic fibrosis. J Clin Microbiol 2004;42:4824-4827.
48. Coutinho CP, Dos Santos SC, Madeira A, Mira NP, Moreira AS, Sá-Correia I. Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations. Front Cell Infect Microbiol 2011;1:12.
49. Mahenthiralingam E, Simpson DA, Speert DP. Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol 1997;35:808-816.
50. Baldwin A, Mahenthiralingam E, Drevinek P, Pope C, Waine DJ, Henry DA, Speert DP, Carter P, Vandamme P, LiPuma JJ, et al. Elucidating global epidemiology of Burkholderia multivorans in cases of cystic fibrosis by multilocus sequence typing. J Clin Microbiol 2008;46: 290-295.
51. Frangolias DD, Mahenthiralingam E, Rae S, Raboud JM, Davidson AG, Wittmann R, Wilcox PG. Burkholderia cepacia in cystic fibrosis: variable disease course. Am J Respir Crit Care Med 1999;160: 1572-1577.